Sign in
4

Changes in Ownership

MADRIGAL PHARMACEUTICALS, INC. Filed Acc 0001628280-25-011321

Chief Commercial Officer acquired 3,386 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Huntsman Carole Chief Commercial Officer 2025-03-05 Grant or award +3,386 11,990 D
Derivatives
Huntsman Carole Chief Commercial Officer 2025-03-05 Grant or award · Stock Option (Right to Buy) +5,703 5,703 D
Loading xslF345X05/wk-form4_1741383098.xml…